Latest News from EarliTec

Join our Mailing List

NEWS & EVENTS

News
Apr 2, 2024
EarliTec Diagnostics, Inc. Raises $21.5 Million in Series B Financing; Funds to Accelerate Commercialization of EarliPoint Evaluation and Further Product Development
• Funding round led by Nexus NeuroTech Ventures and Venture Investors Health Fund • New investment will...
News
Sep 5, 2023
JAMA Publishes Two Large Studies Demonstrating the Diagnostic Accuracy of EarliTec’s Evaluation for Autism in Children as Young as 16 Months
Data show that the clinically-validated, FDA-authorized EarliPointTM Evaluation for autism can provide...
News
Jul 13, 2023
EarliTec Diagnostics Receives FDA 510(k) Authorization for Next-Generation EarliPoint Evaluation for Autism
The second generation of EarliPoint™ Evaluation uses a tablet to aid clinicians in diagnosing and assessing...
News
Jun 10, 2022
EarliTec Diagnostics Receives FDA 510(k) Clearance for the EarliPoint Evaluation for Autism
First FDA-cleared tool to assist clinicians in diagnosing and assessing autism in children as young as...
News
Feb 18, 2022
EarliTec Diagnostics Announces $19.5 Million Financing to Advance Autism Diagnosis and Treatment in Children as Young as 16 Months of Age
EarliTec Diagnostics Announces $19.5 Million Financing to Advance Autism Diagnosis and Treatment in Children...